Potassium Phosphate Replacement in Specific Clinical Scenarios

Dosing and Administration

In diabetic ketoacidosis (DKA), potassium replacement should be initiated after serum levels fall below 5.5 mEq/L, assuming adequate urine output, as recommended by the American Diabetes Association 1, 2
For DKA patients, generally 20-30 mEq potassium (2/3 KCl and 1/3 KPO₄) in each liter of infusion fluid is sufficient to maintain normal serum potassium, according to the American Diabetes Association 1
In critically ill patients on continuous kidney replacement therapy (CKRT), consider using dialysis solutions containing phosphate to prevent CKRT-related hypophosphatemia, as suggested by the European Society for Clinical Nutrition and Metabolism 3, 4
Overzealous phosphate therapy can cause severe hypocalcemia, as warned by the American Diabetes Association 2